Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06623539
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-09-30
Brief Title:
Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver Disease
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Pemafibrate for Treating NAFLD Complicated by Hypertriglyceridemia A Multi-center Open Study Randomized Controlled Trial PRESENT Study
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a study to evaluate the effect of pemafibrate on fatty liver in patients with hypertgemia combined with NAFLD using fenofibrate as a control
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None